Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$123,057,427
+$5,423,770 QoQ
Shares Held
339,825
+1.6% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#126
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. AMGN ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
This page
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,057,427 | 339,825 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $117,633,657 | 334,329 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $94,259,387 | 287,982 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $79,529,321 | 281,819 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $79,443,061 | 284,528 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $96,330,636 | 309,198 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $87,514,830 | 335,769 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $111,671,861 | 346,581 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $104,438,598 | 334,257 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $97,546,494 | 343,087 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $102,347,617 | 355,349 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $83,649,936 | 311,244 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $68,826,643 | 310,002 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $91,248,294 | 377,449 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $102,696,440 | 391,016 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $89,185,820 | 395,678 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $105,054,262 | 431,789 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $91,834,771 | 379,765 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $96,948,120 | 430,938 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $88,656,123 | 416,911 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $100,893,242 | 413,921 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $90,097,086 | 362,112 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $88,232,719 | 383,754 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $94,972,474 | 373,672 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $85,795,017 | 363,754 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $77,967,118 | 384,586 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||